First choice for refractory OAB: onabotulinumtoxinA or sacral nerve stimulation

AUTHORS
Andrea Russo and Toby Chai

PEER REVIEWERS
Sohier Elneil and Andrea Tubaro

DATE OF PUBLICATION
October 2016

DOI
https://doi.org/10.18591/BJUIK.0055

An updated version of this module was published in February 2024.

Updated version: https://doi.org/10.18591/BJUIK.0055.v2

If you are a BJUI Knowledge subscriber and would like to view the previous version please contact support@bjuiknowledge.info